Dxcover Expands Leadership Team with Clinical and Commercial Experts
Cancer diagnostics company adds three clinical advisors and two board members to support commercial growth and platform expansion.
Cancer diagnostics company adds three clinical advisors and two board members to support commercial growth and platform expansion.
NeoGenomics has launched PanTracer Tissue and PanTracer Tissue + HRD, advanced solid tumor profiling assays.
Oncologists are seeing more advanced cancer cases due to screening barriers and are concerned current tests aren't effective enough.
The ORACLE test can predict lung cancer survival at diagnosis accurately, offering new hope for tailored treatments in stage 1 patients.
Read MoreLeica Biosystems and Indica Labs will develop a next-gen digital pathology platform and accelerate AI-enabled CDx for cancer care.
Read MoreA new study introduced an AI-powered diagnostic model with 94.49% accuracy to improve skin cancer detection and patient outcomes.
Read MoreGenomenon, Inc. has announced the development of the G3 knowledgebase, an advanced genomic AI platform that consolidates genomic data.
Read MoreFunction Health will offer GRAIL’s Galleri multi-cancer early detection test, empowering proactive cancer care through a simple blood draw.
Read MoreResearchers identified 27 protein biomarkers in blood serum that can predict cardiomyopathy risk in pediatric cancer survivors.
Read MoreThe Center for Innovation and Translation of POC Technologies for Equitable Cancer Care showcased POC innovations for cancer detection.
Read MoreSakura Finetek Europe and MEDIPATH partnered to enhance cancer diagnostics by deploying automated embedding systems in key pathology centers.
Read MoreResearchers have developed a novel testing strategy for mesothelioma cancer, focusing on detecting chromosomal rearrangements in cancer DNA.
Read MoreResearchers developed a non-invasive cancer detection tool using nanowire-based miRNA extraction and AI to identify lung cancer in urine.
Read MoreA study found that the teledermoscopy system achieved 91% diagnostic accuracy for skin cancer, closely matching in-person evaluations.
Read MoreA new AI-driven tool enables neurosurgeons to detect residual brain tumor tissue in seconds, reducing the likelihood of cancer recurrence.
Read MoreA blood test identifies early lung damage in cancer patients taking antibody–drug conjugates, offering an alternative to imaging scans.
Read MoreThe NCCN updated its Clinical Practice Guidelines to broaden genetic testing recommendations for high-risk cancer types.
Read MoreCaris Life Sciences’ MI Cancer Seek CDx assay received FDA approval to help identify cancer patients who may benefit from targeted therapies.
Read More